Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Durand

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Carbohydrate Polymers|June 17, 2015
First multi-reactive dextran-based inisurf for atom transfer radical polymerization in miniemulsionMan Wu, Laura M Forero Ramirez, Ana Rodriguez Lozano, et al.
Carbohydrate Polymers|September 2, 2019
First multi-reactive polysaccharide-based transurf to produce potentially biocompatible dextran-covered nanocapsulesLaura Marcela Forero Ramirez, Jérôme Babin, Ariane Boudier, et al.
Biochemical and Biophysical Research Communications|August 25, 2004
Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressorFrédérique Fallone, Pierre-Henri Villard, Eric Sérée, et al.
Cancer Chemotherapy and Pharmacology|November 18, 2005
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiencyJoseph Ciccolini, Cedric Mercier, Laetitia Dahan, et al.
Nanomaterials (Basel, Switzerland)|June 10, 2022
Effect of Silica Nanoparticles in Xanthan Gum Solutions: Evolution of Viscosity over TimeDayan L Buitrago-Rincon, Véronique Sadtler, Ronald A Mercado, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitorCaroline Solas, Isabelle Poizot-Martin, Marie-Pierre Drogoul, et al.
Anti-Cancer Drugs|May 31, 2008
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategyCharlotte Dupuis, Cedric Mercier, Chenguang Yang, et al.
Therapeutic Drug Monitoring|October 14, 2006
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapyJoseph Ciccolini, Cédric Mercier, Alexandre Evrard, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Carbohydrate Polymers|June 17, 2015
First multi-reactive dextran-based inisurf for atom transfer radical polymerization in miniemulsionMan Wu, Laura M Forero Ramirez, Ana Rodriguez Lozano, et al.
Carbohydrate Polymers|September 2, 2019
First multi-reactive polysaccharide-based transurf to produce potentially biocompatible dextran-covered nanocapsulesLaura Marcela Forero Ramirez, Jérôme Babin, Ariane Boudier, et al.
Biochemical and Biophysical Research Communications|August 25, 2004
Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressorFrédérique Fallone, Pierre-Henri Villard, Eric Sérée, et al.
Cancer Chemotherapy and Pharmacology|November 18, 2005
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiencyJoseph Ciccolini, Cedric Mercier, Laetitia Dahan, et al.
Nanomaterials (Basel, Switzerland)|June 10, 2022
Effect of Silica Nanoparticles in Xanthan Gum Solutions: Evolution of Viscosity over TimeDayan L Buitrago-Rincon, Véronique Sadtler, Ronald A Mercado, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitorCaroline Solas, Isabelle Poizot-Martin, Marie-Pierre Drogoul, et al.
Anti-Cancer Drugs|May 31, 2008
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategyCharlotte Dupuis, Cedric Mercier, Chenguang Yang, et al.
Therapeutic Drug Monitoring|October 14, 2006
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapyJoseph Ciccolini, Cédric Mercier, Alexandre Evrard, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
Pageof 5